Shanghai Rightongene Valuation

688217 Stock   21.07  0.83  3.79%   
At this time, the company appears to be overvalued. Shanghai Rightongene has a current Real Value of USD16.49 per share. The regular price of the company is USD21.07. Our model measures the value of Shanghai Rightongene from inspecting the company fundamentals such as Shares Outstanding of 55.86 M, return on equity of -0.0148, and Operating Margin of 0.03 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book
1.3143
Enterprise Value
B
Enterprise Value Ebitda
16.4695
Price Sales
4.726
Enterprise Value Revenue
4.1093
Overvalued
Today
21.07
Please note that Shanghai Rightongene's price fluctuation is somewhat reliable at this time. Calculation of the real value of Shanghai Rightongene is based on 3 months time horizon. Increasing Shanghai Rightongene's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shanghai Rightongene is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shanghai Stock. However, Shanghai Rightongene's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  21.07 Real  16.49 Hype  21.55
The real value of Shanghai Stock, also known as its intrinsic value, is the underlying worth of Shanghai Rightongene Company, which is reflected in its stock price. It is based on Shanghai Rightongene's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shanghai Rightongene's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
16.49
Real Value
21.40
Upside
Estimating the potential upside or downside of Shanghai Rightongene Biotechnology helps investors to forecast how Shanghai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shanghai Rightongene more accurately as focusing exclusively on Shanghai Rightongene's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
16.6421.5526.46
Details

Shanghai Rightongene Cash

167 Million

Shanghai Rightongene Total Value Analysis

Shanghai Rightongene Biotechnology is presently forecasted to have takeover price of 1.02 B with market capitalization of 1.18 B, debt of 5.82 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shanghai Rightongene fundamentals before making investing decisions based on enterprise value of the company

Shanghai Rightongene Investor Information

About 41.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.31. In the past many companies with similar price-to-book ratios have beat the market. Shanghai Rightongene recorded a loss per share of 0.1. The entity last dividend was issued on the 30th of November 2023. Based on the measurements of operating efficiency obtained from Shanghai Rightongene's historical financial statements, Shanghai Rightongene Biotechnology is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities61.1 M45.1 M
Significantly Up
Slightly volatile
Operating Income334.7 K352.3 K
Notably Down
Pretty Stable

Shanghai Rightongene Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Shanghai suggests not a very effective usage of assets in November.
 
Covid

Shanghai Rightongene Ownership Allocation

Shanghai Rightongene shows a total of 55.86 Million outstanding shares. Shanghai Rightongene maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Shanghai Rightongene Profitability Analysis

The company reported the revenue of 258.21 M. Net Income was 7.93 M with profit before overhead, payroll, taxes, and interest of 257.7 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Shanghai Rightongene's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Shanghai Rightongene and how it compares across the competition.

About Shanghai Rightongene Valuation

The stock valuation mechanism determines Shanghai Rightongene's current worth on a weekly basis. Our valuation model uses a comparative analysis of Shanghai Rightongene. We calculate exposure to Shanghai Rightongene's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shanghai Rightongene's related companies.
Last ReportedProjected for Next Year
Gross Profit189 M235.5 M

Shanghai Rightongene Quarterly Retained Earnings

163.25 Million

Complementary Tools for Shanghai Stock analysis

When running Shanghai Rightongene's price analysis, check to measure Shanghai Rightongene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rightongene is operating at the current time. Most of Shanghai Rightongene's value examination focuses on studying past and present price action to predict the probability of Shanghai Rightongene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rightongene's price. Additionally, you may evaluate how the addition of Shanghai Rightongene to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Transaction History
View history of all your transactions and understand their impact on performance